Ameriprise Financial »

Denali Therapeutics shares owned by Ameriprise Financial

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Ameriprise Financial from 13F filings

Historical chart of Ameriprise Financial investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Ameriprise Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Ameriprise Financial

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.4M 100k 14.52
2025-06-30 $1.4M 102k 13.99
2024-12-31 $341k 17k 20.38
2024-09-30 $216k 7.4k 29.13